Diadema Partners »

Hims & Hers Heal shares owned by Diadema Partners

Quarter-by-quarter ownership of Hims & Hers Heal (HIMS) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Hims & Hers Heal

Tip: Access up to 7 years of quarterly data

All positions including Hims & Hers Heal held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Hims & Hers Heal by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $14M 394k 34.67

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Hims & Hers Heal

BlackRock
Susquehanna International
Vanguard Portfolio Management
Citadel Advisors
Jane Street
Vanguard Capital Management
Morgan Stanley
Goldman Sachs Group
State Street Corporation
Divisadero Street Capital Management
Geode Capital Management
D. E. Shaw & Co
Jpmorgan Chase & Co
FMR
Marshall Wace

View all funds holding Hims & Hers Heal